KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Return on Sales: 2010-2024

Historic Return on Sales for Supernus Pharmaceuticals (SUPN) over the last 15 years, with Dec 2024 value amounting to 0.11%.

  • Supernus Pharmaceuticals' Return on Sales fell 12.00% to -0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.03%, marking a year-over-year decrease of 12.00%. This contributed to the annual value of 0.11% for FY2024, which is 11.00% up from last year.
  • As of FY2024, Supernus Pharmaceuticals' Return on Sales stood at 0.11%, which was up 5,052.36% from 0.00% recorded in FY2023.
  • Supernus Pharmaceuticals' 5-year Return on Sales high stood at 0.24% for FY2020, and its period low was 0.00% during FY2023.
  • Its 3-year average for Return on Sales is 0.07%, with a median of 0.09% in 2022.
  • Its Return on Sales has fluctuated over the past 5 years, first decreased by 15bps in 2021, then climbed by 11bps in 2024.
  • Yearly analysis of 5 years shows Supernus Pharmaceuticals' Return on Sales stood at 0.24% in 2020, then declined by 15bps to 0.09% in 2021, then remained steady at 0.09% in 2022, then fell by 9bps to 0.00% in 2023, then increased by 11bps to 0.11% in 2024.